The effect of external pH changes on responses to excitatory amino acids in mouse hippocampal neurones
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články
PubMed
1707970
PubMed Central
PMC1181750
DOI
10.1113/jphysiol.1990.sp018304
Knihovny.cz E-zdroje
- MeSH
- akční potenciály účinky léků MeSH
- aminokyseliny farmakologie MeSH
- glutamáty farmakologie MeSH
- hipokampus fyziologie MeSH
- hořčík farmakologie MeSH
- iontové kanály účinky léků MeSH
- koncentrace vodíkových iontů MeSH
- kultivované buňky MeSH
- kyselina chischalová farmakologie MeSH
- kyselina kainová farmakologie MeSH
- myši inbrední BALB C MeSH
- myši MeSH
- N-methylaspartát farmakologie MeSH
- neurony účinky léků MeSH
- zinek farmakologie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- aminokyseliny MeSH
- glutamáty MeSH
- hořčík MeSH
- iontové kanály MeSH
- kyselina chischalová MeSH
- kyselina kainová MeSH
- N-methylaspartát MeSH
- zinek MeSH
1. The whole-cell and outside-out configurations of the patch-clamp technique were used to record responses to excitatory amino acids in mouse hippocampal neurones in cell culture at different pH. The amino acids kainate, quisqualate, N-methyl-D-aspartate (NMDA) and L-glutamate were applied by a rapid perfusion system. 2. In the whole-cell recording mode the responses to NMDA or to low concentrations of glutamate, recorded in the absence of Mg2+ and with glycine in the extracellular superfusion solution, were antagonized by acidic pH and potentiated by an alkaline extracellular solution. Decrease in pH from 7.3 to 6.0 reduced NMDA responses to 33 +/- 2% and an increase in pH from 7.3 to 8.0 potentiated it to 141 +/- 6%. The responses to quisqualate and kainate were only slightly changed by altering the pH from 7.3 to 6.3 or 8.3. 3. The equilibrium dissociation constant (Kd) for H+ antagonism of responses to NMDA, estimated from the fit of a single-binding-site adsorption isotherm, was calculated to be 0.25 +/- 0.06 microM, corresponding to pH 6.6 +/- 0.1. The H+ attenuation of NMDA current was voltage independent at membrane potentials -60 to +30 mV. 4. H+ antagonism of responses to NMDA was reduced when the NMDA concentration was lowered. In the pH range 6.3-8.3 the H(+)-induced reduction did not vary with the concentration of glycine or Mg2+. The sensitivity of NMDA current to Zn2+ was unchanged in the pH range 6.3 +/- 8.0. These results suggest that H+ ions do not directly interfere with the binding of NMDA to its agonist recognition site or with the binding of glycine, Mg2+ and Zn2+ to the specific allosteric sites on the NMDA receptor-channel complex. 5. In outside-out patches held at -60 mV, unitary NMDA-activated currents were recorded at pH 7.3 and 6.3. The mean NMDA single-channel conductance (gamma) obtained for the largest and most frequent openings were: gamma 7.3 = 52.5 +/- 0.8 pS and gamma 6.3 = 51.8 +/- 0.9 pS. The duration of the mean channel open time, tau o, decreased from 4.75 +/- 0.25 ms in the control at pH 7.3 to 3.59 +/- 0.21 ms at pH 6.3. The mean burst duration, tau b, was reduced from 8.51 +/- 0.78 ms at control pH 7.3 to 5.1 +/- 0.34 ms at pH 6.3. The frequency of NMDA channel bursts was reduced by 31%.(ABSTRACT TRUNCATED AT 400 WORDS)
Zobrazit více v PubMed
Biochem J. 1936 Nov;30(11):2085-94 PubMed
J Physiol. 1990 Sep;428:313-31 PubMed
J Physiol. 1988 May;399:247-66 PubMed
J Physiol. 1988 May;399:207-26 PubMed
J Physiol. 1989 Aug;415:329-50 PubMed
J Physiol. 1985 Dec;369:501-57 PubMed
J Physiol. 1987 May;386:603-33 PubMed
J Cereb Blood Flow Metab. 1989 Apr;9(2):127-40 PubMed
J Cereb Blood Flow Metab. 1987 Oct;7(5):599-604 PubMed
J Neurochem. 1986 Feb;46(2):331-9 PubMed
Brain Res. 1987 Sep 15;420(2):313-23 PubMed
Science. 1987 May 1;236(4801):589-93 PubMed
Nature. 1986 Feb 27-Mar 5;319(6056):774-6 PubMed
Prog Neurobiol. 1987;28(3):197-276 PubMed
Neurosci Lett. 1988 Jun 29;89(2):198-203 PubMed
Proc Natl Acad Sci U S A. 1988 Sep;85(17):6547-50 PubMed
Neurosci Lett. 1988 Oct 31;93(1):73-8 PubMed
Nature. 1987 Aug 13-19;328(6131):640-3 PubMed
Neuron. 1989 Mar;2(3):1221-7 PubMed
Pflugers Arch. 1981 Aug;391(2):85-100 PubMed
J Neurophysiol. 1983 Mar;49(3):831-50 PubMed
J Physiol. 1979 Oct;295:139-70 PubMed
J Physiol. 1978 Jun;279:167-85 PubMed
J Physiol. 1977 May;267(2):429-63 PubMed
Pflugers Arch. 1978 Dec 15;378(1):47-53 PubMed
J Neurochem. 1979 Jan;32(1):121-7 PubMed
J Physiol. 1967 Apr;189(3):403-25 PubMed
J Gen Physiol. 1973 Jun;61(6):687-708 PubMed
Proc R Soc Lond B Biol Sci. 1988 May 23;233(1273):407-22 PubMed
Nature. 1987 Sep 17-23;329(6136):243-6 PubMed
J Neurosci. 1987 Oct;7(10):3230-44 PubMed
Nature. 1987 Dec 17-23;330(6149):649-52 PubMed
Nature. 1987 Feb 5-11;325(6104):529-31 PubMed
Nature. 1987 Feb 5-11;325(6104):525-8 PubMed
Proc Natl Acad Sci U S A. 1989 Feb;86(4):1411-5 PubMed
Cell Mol Neurobiol. 1989 Mar;9(1):95-104 PubMed
Nature. 1989 Mar 30;338(6214):425-7 PubMed
J Neurophysiol. 1988 Aug;60(2):645-63 PubMed
Nature. 1987 Mar 12-18;326(6109):183-5 PubMed
J Cereb Blood Flow Metab. 1985 Mar;5(1):47-57 PubMed
J Cereb Blood Flow Metab. 1984 Mar;4(1):17-27 PubMed
Annu Rev Pharmacol Toxicol. 1981;21:165-204 PubMed
Brain Res. 1984 May;319(2):103-64 PubMed
Br J Pharmacol. 1983 Jun;79(2):565-75 PubMed
Nature. 1984 May 17-23;309(5965):261-3 PubMed
Nature. 1984 Feb 2-8;307(5950):462-5 PubMed